NDC 53163-104 Altipres

Dextromethorphan Hbr, Guaifenesin, Phenylephrine Hcl

NDC Product Code 53163-104

NDC CODE: 53163-104

Proprietary Name: Altipres What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.

Non-Proprietary Name: Dextromethorphan Hbr, Guaifenesin, Phenylephrine Hcl What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

Product Characteristics


NDC Code Structure

  • 53163 - Alternative Pharmacal Corporation

NDC 53163-104-16

Package Description: 473 mL in 1 BOTTLE

NDC Product Information

Altipres with NDC 53163-104 is a a human over the counter drug product labeled by Alternative Pharmacal Corporation. The generic name of Altipres is dextromethorphan hbr, guaifenesin, phenylephrine hcl. The product's dosage form is liquid and is administered via oral form. The RxNorm Crosswalk for this NDC code indicates a single RxCUI concept is associated to this product: 1098647.

Dosage Form: Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.

Product Type: Human Otc Drug What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

Altipres Active Ingredient(s)

What is the Active Ingredient(s) List?
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.

Inactive Ingredient(s)

About the Inactive Ingredient(s)
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product.

  • FD&C RED NO. 40 (UNII: WZB9127XOA)
  • WATER (UNII: 059QF0KO0R)

Administration Route(s)

What are the Administration Route(s)?
The translation of the route code submitted by the firm, indicating route of administration.

  • Oral - Administration to or by way of the mouth.

Product Labeler Information

What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.

Labeler Name: Alternative Pharmacal Corporation
Labeler Code: 53163
FDA Application Number: part341 What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

Marketing Category: OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph. What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Start Marketing Date: 05-01-2013 What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.

Listing Expiration Date: 12-31-2021 What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.

Exclude Flag: N - NO What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".

* Please review the disclaimer below.

Information for Patients


Dextromethorphan is pronounced as (dex troe meth or' fan)

Why is dextromethorphan medication prescribed?
Dextromethorphan is used to temporarily relieve cough caused by the common cold, the flu, or other conditions. Dextromethorphan will relieve a cough but will not treat th...
[Read More]

Guaifenesin is pronounced as (gwye fen' e sin)
Why is guaifenesin medication prescribed?
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a cla...
[Read More]

Phenylephrine is pronounced as (fen il ef' rin)
Why is phenylephrine medication prescribed?
Phenylephrine is used to relieve nasal discomfort caused by colds, allergies, and hay fever. It is also used to relieve sinus congestion and pressure. Phenylephrine will ...
[Read More]

* Please review the disclaimer below.

Altipres Product Label Images

Altipres Product Labeling Information

The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Product Labeling Index

Otc - Active Ingredient

Active Ingredients (in each 5 mL tsp.)              PurposeDextromethorphan HBr ............... 10 mg ................ Cough SuppressantGuaifenesin .............................. 200 mg ................ ExpectorantPhenylephrine HCl ..................... 5 mg ................... Nasal Decongestant

Otc - Purpose

PurposeCough SuppressantExpectorantNasal Decongestant


  • WarningsAsk a doctor before use if you haveheart diseasehigh blood pressurethyroid diseasediabetestrouble urinating due to the enlargement of the prostate glanda cough that occurs with too much phlegm (mucus) cough that lasts or is chronic as occurs with smoking, asthma, chronic bronchitis or emphysemaWhen using this product, do not exceed recommended dosageStop use and ask doctor ifyou get nervous, dizzy or sleeplesssymptoms do not get better within 7 days or are accompanied by fevercough lasts more than 7 days, comes back or is accompanied by fever, rash or persistent headache. These could be signs of a serious condition

Otc - Do Not Use

  • Do not useif you are now taking a prescription Monoamine Oxidase Inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if you are taking a prescription drug that contains an MAOI; ask a doctor or pharmacist before taking this product -Do not use- in a child under 2 years of age

Otc - Pregnancy Or Breast Feeding

If pregnant or breast-feeding,ask a health professional before use.

Otc - Keep Out Of Reach Of Children

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Indications & Usage

  • Useshelps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubestemporarily relieves nasal congestion due to the common cold and cough due to minor throat and bronchial irritation

Dosage & Administration

Directions  Do not exceed more than 6 doses in any 24-hour periodadults and children 12 years of age and overtake 2 teaspoonfuls (10 mL) every 4 hourschildren 6 to under 12 years of agetake 1 teaspoonful (5 mL) every 4 hourschildren 2 years to under 6 years of agetake 1/2 teaspoonful (2.5 mL) every 4 hourschildren under 2 years of ageask a doctor

Inactive Ingredient

Inactive ingredients  citric acid, cherry flavor, FD and C red No. 40, glycerin, methylparaben, polyethylene glycol, propylparaben, purified water, sodium citrate and sucralos

Otc - Questions

Questions or comments? 1-305-403-3788

* Please review the disclaimer below.